David Bearss


Tolero Pharmaceuticals, Inc.

Dave graduated with a PhD in Cell and Structural Biology from the University of Texas. He went on to found Montigen Pharmaceuticals in 2003 which sold to SuperGen in 2006. After working as the VP, Chief Scientist, and Chief Scientific Officer for SuperGen, Dave started The Center for Investigational Therapeutics and worked as an associate professor at The Huntsman Cancer Institute and The Department of Oncological Sciences. Dave co-founded, and leads as CEO, Tolero Pharmaceuticals in 2011. Dave’s career also includes teaching positions with the University of Arizona, Salt Lake Community College, University of Utah and Brigham Young University. Dave’s passion still lies in the science behind drug discovery and development.